Search Results

There are 97358 results for: content related to: MDMA and 5-HT neurotoxicity: the empirical evidence for its adverse effects in humans – no need for translation

  1. Methylenedioxymethamphetamine (Ecstasy, MDMA)

    Medical Toxicology of Drug Abuse: Synthesized Chemicals and Psychoactive Plants

    Donald G. Barceloux, Pages: 126–155, 2012

    Published Online : 2 FEB 2012, DOI: 10.1002/9781118105955.ch9

  2. MDMA is certainly damaging after 25 years of empirical research: a reply and refutation of Doblin et al. (2014)

    Human Psychopharmacology: Clinical and Experimental

    Volume 29, Issue 2, March 2014, Pages: 109–119, Andrew C. Parrott

    Article first published online : 3 MAR 2014, DOI: 10.1002/hup.2390

  3. You have free access to this content
    Lost in translation: preclinical studies on 3,4-methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humans

    British Journal of Pharmacology

    Volume 166, Issue 5, July 2012, Pages: 1523–1536, AR Green, MV King, SE Shortall and KCF Fone

    Article first published online : 21 JUN 2012, DOI: 10.1111/j.1476-5381.2011.01819.x

  4. You have free access to this content
    The Neuropsychopharmacology and Toxicology of 3,4-methylenedioxy-N-ethyl-amphetamine (MDEA)

    CNS Drug Reviews

    Volume 10, Issue 2, June 2004, Pages: 89–116, Roland W. Freudenmann and Manfred Spitzer

    Article first published online : 7 JUN 2006, DOI: 10.1111/j.1527-3458.2004.tb00007.x

  5. Major depression: the relative contribution of gender, MDMA, and cannabis use

    Depression and Anxiety

    Volume 25, Issue 3, March 2008, Pages: 241–247, Heather Durdle, Leslie H. Lundahl, Chris-Ellyn Johanson and Manuel Tancer

    Article first published online : 7 MAR 2007, DOI: 10.1002/da.20297

  6. A Comprehensive Review of MDMA and GHB: Two Common Club Drugs

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 21, Issue 12, December 2001, Pages: 1486–1513, Christian J. Teter and Sally K. Guthrie

    Article first published online : 17 JAN 2012, DOI: 10.1592/phco.21.20.1486.34472

  7. You have free access to this content
    The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives

    British Journal of Pharmacology

    Volume 160, Issue 5, July 2010, Pages: 1029–1044, JR Docherty and AR Green

    Article first published online : 3 MAR 2010, DOI: 10.1111/j.1476-5381.2010.00722.x

  8. You have free access to this content
    Mechanisms mediating the ability of caffeine to influence MDMA (‘Ecstasy’)-induced hyperthermia in rats

    British Journal of Pharmacology

    Volume 160, Issue 4, June 2010, Pages: 860–877, N Vanattou-Saïfoudine, R McNamara and A Harkin

    Article first published online : 24 MAY 2010, DOI: 10.1111/j.1476-5381.2010.00660.x

  9. Substance Abuse: Hallucinogen- and MDMA-Related Disorders

    Psychiatry, Third Edition

    Rif S. El-Mallakh, John H. Halpern, Henry D. Abraham, Pages: 1100–1126, 2008

    Published Online : 8 AUG 2008, DOI: 10.1002/9780470515167.ch60

  10. Acute, sub-acute and long-term subjective consequences of ‘ecstasy’ (MDMA) consumption in 430 regular users

    Human Psychopharmacology: Clinical and Experimental

    Volume 18, Issue 7, October 2003, Pages: 507–517, Suzanne L. Verheyden, John A. Henry and H. Valerie Curran

    Article first published online : 1 OCT 2003, DOI: 10.1002/hup.529

  11. You have free access to this content
    The preclinical pharmacology of mephedrone; not just MDMA by another name

    British Journal of Pharmacology

    Volume 171, Issue 9, May 2014, Pages: 2251–2268, A R Green, M V King, S E Shortall and K C F Fone

    Article first published online : 11 APR 2014, DOI: 10.1111/bph.12628

  12. Why all stimulant drugs are damaging to recreational users: an empirical overview and psychobiological explanation

    Human Psychopharmacology: Clinical and Experimental

    Volume 30, Issue 4, July 2015, Pages: 213–224, Andrew C. Parrott

    Article first published online : 28 JUL 2015, DOI: 10.1002/hup.2468

  13. Adolescent pre-exposure to ethanol and 3,4-methylenedioxymethylamphetamine (MDMA) increases conditioned rewarding effects of MDMA and drug-induced reinstatement

    Addiction Biology

    Volume 17, Issue 3, May 2012, Pages: 588–600, Bruno Ribeiro Do Couto, Manuel Daza-Losada, Marta Rodríguez-Arias, Roser Nadal, Consuelo Guerri, Teresa Summavielle, Jose Miñarro and Maria A. Aguilar

    Article first published online : 13 OCT 2011, DOI: 10.1111/j.1369-1600.2011.00382.x

  14. You have free access to this content
    Pro-oxidant effects of Ecstasy and its metabolites in mouse brain synaptosomes

    British Journal of Pharmacology

    Volume 165, Issue 4b, February 2012, Pages: 1017–1033, Daniel José Barbosa, João Paulo Capela, Jorge MA Oliveira, Renata Silva, Luísa Maria Ferreira, Filipa Siopa, Paula Sério Branco, Eduarda Fernandes, José Alberto Duarte, Maria de Lourdes Bastos and Félix Carvalho

    Article first published online : 26 JAN 2012, DOI: 10.1111/j.1476-5381.2011.01453.x

  15. The Norepinephrine Transporter Inhibitor Reboxetine Reduces Stimulant Effects of MDMA (“Ecstasy”) in Humans

    Clinical Pharmacology & Therapeutics

    Volume 90, Issue 2, August 2011, Pages: 246–255, CM Hysek, LD Simmler, M Ineichen, E Grouzmann, MC Hoener, R Brenneisen, J Huwyler and ME Liechti

    Article first published online : 15 JUN 2011, DOI: 10.1038/clpt.2011.78

  16. Treatment Implications for Young Adult Users of MDMA

    Journal of Addictions & Offender Counseling

    Volume 26, Issue 2, April 2006, Pages: 84–98, Brian J. Dew, Kirk W. Elifson and Claire E. Sterk

    Article first published online : 23 DEC 2011, DOI: 10.1002/j.2161-1874.2006.tb00010.x

  17. Interaction of 3,4-Methylenedioxymethamphetamine and Methamphetamine During Metabolism by In Vitro Human Metabolic Enzymes and in Rats

    Journal of Forensic Sciences

    Volume 57, Issue 4, July 2012, Pages: 1008–1013, Kenji Kuwayama, Kenji Tsujikawa, Hajime Miyaguchi, Tatsuyuki Kanamori, Yuko T. Iwata and Hiroyuki Inoue

    Article first published online : 28 DEC 2011, DOI: 10.1111/j.1556-4029.2011.02039.x

  18. You have free access to this content
    Methylenedioxymethamphetamine inhibits mitochondrial complex I activity in mice: a possible mechanism underlying neurotoxicity

    British Journal of Pharmacology

    Volume 160, Issue 2, May 2010, Pages: 233–245, Elena Puerta, Isabel Hervias, Beatriz Goñi-Allo, Steven F Zhang, Joaquín Jordán, Anatoly A Starkov and Norberto Aguirre

    Article first published online : 23 MAR 2010, DOI: 10.1111/j.1476-5381.2010.00663.x

  19. You have free access to this content
    Effects of 3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats

    British Journal of Pharmacology

    Volume 171, Issue 1, January 2014, Pages: 83–91, Charles W Schindler, Eric B Thorndike, Bruce E Blough, Srihari R Tella, Steven R Goldberg and Michael H Baumann

    Article first published online : 10 DEC 2013, DOI: 10.1111/bph.12423

  20. You have free access to this content
    Active and passive MDMA (‘ecstasy’) intake induces differential transcriptional changes in the mouse brain

    Genes, Brain and Behavior

    Volume 11, Issue 1, February 2012, Pages: 38–51, N. Fernàndez-Castillo, M. J. Orejarena, M. Ribasés, E. Blanco, M. Casas, P. Robledo, R. Maldonado and B. Cormand

    Article first published online : 16 NOV 2011, DOI: 10.1111/j.1601-183X.2011.00735.x